{
    "2020-02-12": [
        [
            {
                "time": "2020-01-20",
                "original_text": "Coronavirus outbreak begins to disrupt booming China drug trials",
                "features": {
                    "keywords": [
                        "Coronavirus",
                        "outbreak",
                        "disrupt",
                        "booming",
                        "China",
                        "drug trials"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-02-15",
                "original_text": "Buy AbbVie for its Growth Prospects, Yield and Low Valuation",
                "features": {
                    "keywords": [
                        "Buy",
                        "AbbVie",
                        "Growth Prospects",
                        "Yield",
                        "Low Valuation"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-03-10",
                "original_text": "The Daily Biotech Pulse: J&J Intensifies Efforts On COVID-19 Cure, Adamas Reports Positive, Long-Term Gocovri Data",
                "features": {
                    "keywords": [
                        "Biotech",
                        "J&J",
                        "COVID-19",
                        "Cure",
                        "Adamas",
                        "Positive",
                        "Long-Term",
                        "Gocovri",
                        "Data"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}